What is Perspectum?
Perspectum operates at the intersection of advanced medical imaging and digital health, providing clinicians with sophisticated, non-invasive diagnostic technologies. The company specializes in addressing the diagnostic gap for patients suffering from chronic metabolic conditions, multi-organ pathologies, and various forms of cancer. By integrating high-fidelity data analytics with clinical workflows, Perspectum enables more precise monitoring and personalized treatment strategies. Its market position is defined by a commitment to evidence-based medicine, supported by deep academic roots and a focus on improving long-term patient outcomes through technological innovation.
How much funding has Perspectum raised?
Perspectum has raised a total of $90.9M across 2 funding rounds:
Series B
$35.9M
Series C
$55M
Series B (2020): $35.9M with participation from Puhua Capital, Oxford Sciences Enterprises, HealthQuest Capital, and Oxford University
Series C (2023): $55M led by Oppenheimer Holdings
Key Investors in Perspectum
HealthQuest Capital
HealthQuest Capital provides growth capital to companies that are transforming healthcare through innovations in medical devices, technologies, healthcare services, and diagnostics.
Oxford Sciences Enterprises
Oxford Science Enterprises is an independent investment company created to found, fund and build transformational businesses via a unique partnership with the University of Oxford.
Puhua Capital
Puhua Capital Ltd is an early-stage growth-equity firm that provides industry resources, management experience, and investment funds to emerging enterprises.
What's next for Perspectum?
Looking ahead, the strategic deployment of the $55M will likely focus on accelerating the regulatory approval processes for new diagnostic modules and scaling the company's commercial infrastructure. As the healthcare industry shifts toward value-based care models, Perspectum's ability to provide actionable, data-driven insights will be critical for maintaining its competitive edge. The company is expected to prioritize the integration of its digital solutions into major hospital networks, further solidifying its role as an essential partner in the modern clinical ecosystem. Future growth will likely be characterized by increased investment in R&D to address emerging pathologies and the expansion of its global sales force to capture market share in high-growth regions.
See full Perspectum company page
